000 01639 a2200469 4500
005 20250516085136.0
264 0 _c20121019
008 201210s 0 0 eng d
022 _a1432-1335
024 7 _a10.1007/s00432-012-1194-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLing, Bo
245 0 0 _aTumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.
_h[electronic resource]
260 _bJournal of cancer research and clinical oncology
_cAug 2012
300 _a1355-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3' Untranslated Regions
_xgenetics
650 0 4 _aAnimals
650 0 4 _aBase Sequence
650 0 4 _aBinding Sites
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Progression
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGenes, Tumor Suppressor
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aReceptor, ErbB-3
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTransfection
650 0 4 _aTumor Burden
_xgenetics
650 0 4 _aXenograft Model Antitumor Assays
_xmethods
700 1 _aWang, Gui-Xue
700 1 _aLong, Guang
700 1 _aQiu, Ju-Hui
700 1 _aHu, Zhong-Lei
773 0 _tJournal of cancer research and clinical oncology
_gvol. 138
_gno. 8
_gp. 1355-61
856 4 0 _uhttps://doi.org/10.1007/s00432-012-1194-2
_zAvailable from publisher's website
999 _c21686854
_d21686854